Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Serge Rozenberg, Nick Panay, Marco Gambacciani, Antonio Cano, Sarah Gray & Katrin Schaudig. (2023) Breaking down barriers for prescribing and using hormone therapy for the treatment of menopausal symptoms: an experts’ perspective. Expert Review of Clinical Pharmacology 16:6, pages 507-517.
Read now
Read now
Geoffrey K. Robinson. (2019) What Properties Might Statistical Inferences Reasonably be Expected to Have?—Crisis and Resolution in Statistical Inference. The American Statistician 73:3, pages 243-252.
Read now
Read now
R. L. Reid. (2019) Hormone therapy and breast cancer: risk communication and the ‘perfect storm’. Climacteric 22:1, pages 13-16.
Read now
Read now
R. D. Langer, J. A. Simon, A. Pines, R. A. Lobo, H. N. Hodis, J. H. Pickar, D. F. Archer, P. M. Sarrel & W. H. Utian. (2017) Menopausal hormone therapy for primary prevention: why the USPSTF is wrong. Climacteric 20:5, pages 402-413.
Read now
Read now
J. E. Blümel, P. Chedraui, G. Barón, Z. Benítez, D. Flores, M. T. Espinoza, G. Gomez, E. González, L. Hernández, S. Lima, M. Martino, A. Montaño, A. Monterrosa, D. Mostajo, E. Ojeda, W. Onatra, C. Robles, J. Saavedra, H. Sánchez, K. Tserotas, M. S. Vallejo & C. Vallejo. (2014) A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI). Climacteric 17:4, pages 433-441.
Read now
Read now
Articles from other publishers (23)
Avrum Z. Bluming, Howard N. Hodis & Robert D. Langer. (2023) 'Tis but a scratch: a critical review of the Women's Health Initiative evidence associating menopausal hormone therapy with the risk of breast cancer. Menopause 30:12, pages 1241-1245.
Crossref
Crossref
Rowan T. Chlebowski & Aaron K. Aragaki. (2023) The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in context. Menopause 30:4, pages 454-461.
Crossref
Crossref
Gargi MukherjeeVaishnavi NatarajanAnindita Chakrabarty. (2022) Menopausal hormone-replacement therapy and breast cancer risk: An updated and simplified view. Journal of Reproductive Healthcare and Medicine 3, pages 4.
Crossref
Crossref
Roger A. Lobo. 2022. Comprehensive Gynecology. Comprehensive Gynecology
255
288.e9
.
Geeta Hampson, Grahame J. Elder, Martine Cohen-Solal & Bo Abrahamsen. (2021) A review and perspective on the assessment, management and prevention of fragility fractures in patients with osteoporosis and chronic kidney disease. Endocrine 73:3, pages 509-529.
Crossref
Crossref
Miriam Heinig, Sarina Schwarz & Ulrike Haug. (2021) Self-selection for mammography screening according to use of hormone replacement therapy: A systematic literature review. Cancer Epidemiology 71, pages 101812.
Crossref
Crossref
J.A. Kanis, C. Cooper, R. Rizzoli & J.-Y. Reginster. (2018) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis International 30:1, pages 3-44.
Crossref
Crossref
Ronée E. Harvey, Maja C. Johnson, Sushant M. Ranadive, Michael J. Joyner, Brian D. Lahr, Virginia M. Miller & Jill N. Barnes. (2017) Aortic hemodynamics in postmenopausal women following cessation of hormone therapy. Physiological Reports 5:23.
Crossref
Crossref
Robert D. Langer, James A. Simon, Amos Pines, Rogerio A. Lobo, Howard N. Hodis, James H. Pickar, David F. Archer, Philip M. Sarrel & Wulf H. Utian. (2017) Menopausal hormone therapy for primary prevention: why the USPSTF is wrong. Menopause 24:10, pages 1101-1112.
Crossref
Crossref
Fiona Chew & Xianwei Wu. (2017) Sources of information influencing the state-of-the-science gap in hormone replacement therapy usage. PLOS ONE 12:2, pages e0171189.
Crossref
Crossref
Donna J. Holmes. 2017. The Arc of Life. The Arc of Life
139
157
.
Riley Bove, Brian C Healy, Alexander Musallam, Bonnie I Glanz, Philip L De Jager & Tanuja Chitnis. (2015) Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort. Multiple Sclerosis Journal 22:7, pages 935-943.
Crossref
Crossref
Robert L. Reid & Bryden A. Magee. (2015) Confronting the challenges of the menopausal transition. Women's Midlife Health 1:1.
Crossref
Crossref
Nilanchali Singh, Shalini Rajaram & Neerja Goel. 2015. Uterine Cancer. Uterine Cancer
425
435
.
John Studd. (2014) Hormone therapy for reproductive depression in women. Post Reproductive Health 20:4, pages 132-137.
Crossref
Crossref
Sorapop Kiatpongsan, Karen Carlson, Sandra Feibelmann & Karen Sepucha. (2014) Decision aid reduces misperceptions about hormone therapy. Menopause 21:1, pages 33-38.
Crossref
Crossref
Rogerio A. Lobo. 2014. Yen & Jaffe's Reproductive Endocrinology. Yen & Jaffe's Reproductive Endocrinology
308
339.e8
.
Leslie D. Ross. 2014. Clinical Biochemistry: Metabolic and Clinical Aspects. Clinical Biochemistry: Metabolic and Clinical Aspects
433
450
.
Catha Fischer, Amanda N. Kallen & Lubna Pal. (2013) Hormone Therapy. Menopause 20:11, pages 1204-1206.
Crossref
Crossref
J. A. Kanis, E. V. McCloskey, H. Johansson, C. Cooper, R. Rizzoli & J.-Y. Reginster. (2012) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis International 24:1, pages 23-57.
Crossref
Crossref
A. Lesur. (2012) 2002–2012 : une décennie maudite pour les estrogènes…. Gynécologie Obstétrique & Fertilité 40:11, pages 631-633.
Crossref
Crossref
Irwin Goldstein. (2012) The Effects of the Women's Health Initiative on Its 10th Year Anniversary. The Journal of Sexual Medicine 9:10, pages 2479-2482.
Crossref
Crossref
Simon Brown. (2012) News and views. Menopause International 18:3, pages 96-98.
Crossref
Crossref